Bicycle Therapeutics (BCYC) Non Operating Income (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Non Operating Income of $4.8 million for Q1 2026, down 17.01% on a QoQ basis from $5.8 million in Q4 2025, and down 42.26% year-over-year from $8.4 million in Q1 2025.
Bicycle Therapeutics (BCYC) Non Operating Income (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Non Operating Income history runs 9 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- Quarterly Non Operating Income fell 42.26% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.7 million (down 37.62% YoY) and the FY2025 annual result came in at $28.3 million, down 21.67% from the prior year.
- Non Operating Income was $4.8 million for Q1 2026 at Bicycle Therapeutics, down from $5.8 million in the prior quarter.
- Across five years, Non Operating Income topped out at $14.7 million in Q4 2024 and bottomed at -$600000.0 in Q1 2022.
- A 5-year average of $4.8 million and a median of $4.8 million in 2026 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2023 — Non Operating Income tumbled 136.0% — and 2024, when it soared 77322.22%.
- Bicycle Therapeutics' Non Operating Income stood at $1.8 million in 2022, then jumped by 200.94% to $5.5 million in 2023, then soared by 169.92% to $14.7 million in 2024, then slumped by 60.49% to $5.8 million in 2025, then slipped by 17.01% to $4.8 million in 2026.
- Business Quant data shows BCYC's Non Operating Income at $4.8 million in Q1 2026, $5.8 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | 4.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.83 Mn |
| Dec 31, 2025 | 5.82 Mn |
| Sep 30, 2025 | 6.66 Mn |
| Jun 30, 2025 | 7.42 Mn |
| Mar 31, 2025 | 8.36 Mn |
| Dec 31, 2024 | 14.73 Mn |
| Sep 30, 2024 | 9.60 Mn |
| Jun 30, 2024 | 6.95 Mn |
| Mar 31, 2024 | 4.80 Mn |
| Dec 31, 2023 | 5.46 Mn |
| Sep 30, 2023 | 3.17 Mn |
| Jun 30, 2023 | -9,000.00 |
| Mar 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 1.81 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | -600,000.00 |
| Dec 31, 2021 | -761,000.00 |
| Sep 30, 2021 | -799,000.00 |
| Jun 30, 2021 | -796,000.00 |